A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.
Hematol Oncol
; 39(1): 60-65, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33103778
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, B-Cell, Marginal Zone
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hematol Oncol
Year:
2021
Type:
Article
Affiliation country:
Switzerland